PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 152 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $69,000 | 0.0% | 13,600 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $69,000 | -17.9% | 13,600 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $84,000 | -51.4% | 13,600 | -63.4% | 0.00% | -50.0% |
| Q1 2019 | $173,000 | +78.4% | 37,200 | +102.2% | 0.00% | +300.0% |
| Q4 2018 | $97,000 | +67.2% | 18,400 | +100.0% | 0.00% | 0.0% |
| Q3 2018 | $58,000 | – | 9,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|